Cyproterone acetate primarily works as an antiandrogen. It directly blocks the action of androgens, like testosterone and dihydrotestosterone (DHT), at their receptor sites in hair follicles. This prevents these hormones from binding and triggering the processes that lead to hair growth in androgen-dependent areas.
Specifically, cyproterone acetate competes with androgens for binding to the androgen receptor. Its higher affinity for the receptor effectively displaces androgens, reducing their stimulatory effects on hair follicle activity. This competitive inhibition is a key element in its mechanism.
Beyond competitive inhibition, cyproterone acetate also exhibits some progestogenic activity. While this aspect is less directly related to hair loss, it can influence overall hormonal balance, potentially impacting the effectiveness of the antiandrogenic effect. The interaction between these actions makes individual responses to the medication variable.
Furthermore, the drug’s impact on the hypothalamic-pituitary-gonadal (HPG) axis should be noted. By reducing androgen production, cyproterone acetate affects the hormonal feedback loops governing testosterone levels. This hormonal modulation contributes to its long-term efficacy in managing androgen-related conditions, including hair loss.
Note: This description offers a simplified explanation. The precise interplay of these mechanisms is complex and varies depending on individual factors.
